The Diagnostic Value of LINC00426 in Type 2 Diabetes and Diabetic Kidney Disease and its Regulatory Effects on Renal Cells.
文献摘要
The study investigates the diagnostic value of LINC00426 in type 2 diabetes (T2DM) and diabetic kidney disease (DKD), along with its regulatory effects on renal cells. The study included 280 T2DM patients (146 cases of DKD), and 186 healthy controls who visited during the same period. Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) confirmed that serum LINC00426 is downregulated in patients with T2DM and DKD. Receiver operating characteristic (ROC) analysis assessed LINC00426's diagnostic value for T2DM and DKD. Multivariate logistic regression identified independent DKD risk factors. LINC00426 showed diagnostic value for both diseases and negatively correlated with the urine albumin-to-creatinine ratio (UACR). Its downregulation independently predicted DKD development. A high-glucose (HG) environment inhibits LINC00426 expression in HK-2 and HGMC cells. CCK8 assay, flow cytometry, and enzyme-linked immunosorbent assays confirmed that HG also suppressed proliferation while promoting apoptosis and inflammation. In contrast, overexpression of LINC00426 enhances the proliferative capacity of HK-2 and HGMC cells, inhibits apoptosis, and reduces inflammatory responses. Downregulation of LINC00426 may exacerbate DKD progression by inhibiting the proliferation of renal cells (HK-2 and HGMC) and promoting apoptosis and inflammatory responses.